Cargando…
Knock-out of the critical nitric oxide synthase regulator DDAH1 in mice impacts amphetamine sensitivity and dopamine metabolism
The enzyme dimethylarginine dimethylaminohydrolase 1 (DDAH1) plays a pivotal role in the regulation of nitric oxide levels by degrading the main endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA). Growing evidence highlight the potential implication of DDAH/ADMA axis in th...
Autores principales: | Kozlova, Alena A., Rubets, Elena, Vareltzoglou, Magdalini R., Jarzebska, Natalia, Ragavan, Vinitha N., Chen, Yingjie, Martens-Lobenhoffer, Jens, Bode-Böger, Stefanie M., Gainetdinov, Raul R., Rodionov, Roman N., Bernhardt, Nadine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460711/ https://www.ncbi.nlm.nih.gov/pubmed/36792833 http://dx.doi.org/10.1007/s00702-023-02597-7 |
Ejemplares similares
-
Assessment of DDAH1 and DDAH2 Contributions to Psychiatric Disorders via In Silico Methods
por: Kozlova, Alena A., et al.
Publicado: (2022) -
Divergent Dimethylarginine Dimethylaminohydrolase Isoenzyme Expression in the Central Nervous System
por: Kozlova, Alena A., et al.
Publicado: (2021) -
The Second Life of Methylarginines as Cardiovascular Targets
por: Jarzebska, Natalia, et al.
Publicado: (2019) -
Inhibition of Dimethylarginine Dimethylaminohydrolase (DDAH) Enzymes as an Emerging Therapeutic Strategy to Target Angiogenesis and Vasculogenic Mimicry in Cancer
por: Hulin, Julie-Ann, et al.
Publicado: (2020) -
A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase
por: Ragavan, Vinitha N., et al.
Publicado: (2023)